Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||||
| Cash from operating activities | -4.87B | -9.12%-1.89B | -446.39%-1.73B | 223.55%499.92M | 154.34%154.51M | -228.16%-284.34M | 221.87M |
| Net profit before non-cash adjustment | ---1.28B | -303.46%-4.96B | -51,115.92%-1.23B | 80.74%-2.4M | 94.85%-12.46M | -330.45%-241.8M | --104.92M |
| Total adjustment of non-cash items | ---3.6B | 1,204.82%2.98B | 199.57%228.07M | -17.36%76.13M | 60.15%92.12M | -34.66%57.52M | --88.04M |
| -Depreciation and amortization | --229.72M | 58.92%192.4M | 80.96%121.07M | 46.49%66.9M | -69.83%45.67M | 75.52%151.36M | --86.24M |
| -Reversal of impairment losses recognized in profit and loss | --1.24B | 2,433.77%1.61B | --63.4M | --0 | ---- | --52.14M | ---- |
| -Share of associates | --390.92M | 839.85%90.57M | -238.93%-12.24M | -115.31%-3.61M | --23.6M | ---- | ---- |
| -Disposal profit | --506.08M | -27.69%140.65M | --194.52M | --0 | 108.95%13.43M | ---150M | --0 |
| -Net exchange gains and losses | --0 | -196.63%-23.86M | 50.04%-8.04M | -499.85%-16.1M | 145.39%4.03M | -3,234.28%-8.87M | --283K |
| -Other non-cash items | ---5.97B | 842.27%969.64M | -551.36%-130.63M | 435.86%28.94M | -58.11%5.4M | 746.49%12.89M | --1.52M |
| Changes in working capital | --5.76M | 112.82%93.67M | -271.42%-730.57M | 469.41%426.19M | 174.80%74.85M | -446.27%-100.07M | --28.9M |
| -Change in receivables | ---1.01B | -38.50%-143.8M | 37.56%-103.83M | -66.36%-166.29M | -273.02%-99.96M | 40.16%-26.8M | ---44.78M |
| -Change in inventory | --4.91M | 100.21%263K | ---123.44M | --0 | ---- | ---- | ---- |
| -Change in prepaid assets | --87.52M | 110.63%45.01M | -34,607.13%-423.43M | ---1.22M | ---- | ---- | ---- |
| -Change in payables | --236.52M | 71.11%393.71M | 83.01%230.09M | 9,603.25%125.73M | -103.51%-1.32M | 27.48%37.66M | --29.54M |
| -Provision for loans, leases and other losses | --116.54M | -441.97%-283.18M | -111.35%-52.25M | 631.08%460.34M | --62.97M | ---- | ---- |
| -Changes in other current assets | --352.6M | 128.81%63.78M | -748.05%-221.36M | -175.57%-26.1M | 128.97%34.54M | -4,048.92%-119.24M | ---2.87M |
| -Changes in other current liabilities | --222.45M | 149.19%17.89M | -207.81%-36.36M | -57.10%33.73M | 846.49%78.63M | -82.33%8.31M | --47.01M |
| Dividends paid (cash flow from operating activities) | |||||||
| Dividends received (cash flow from operating activities) | |||||||
| Interest paid (cash flow from operating activities) | -327.49M | -267.22%-77.89M | -32.53%-21.21M | -134.40%-16.01M | -2,246.39%-6.83M | 79.56%-291K | -1.42M |
| Interest received (cash flow from operating activities) | 5.56M | -32.43%25K | 184.62%37K | 116.67%13K | 50.00%6K | 0.00%4K | 4K |
| Tax refund paid | 1.96M | 57.95%-61.65M | -6,456.40%-146.6M | 22.76%-2.24M | 72.04%-2.9M | -1,088.86%-10.36M | -871K |
| Other operating cash inflow (outflow) | 5.41B | 1,096.23%114.28M | -1,147,000.00%-11.47M | 99.98%-1K | 65.15%-5.25M | -15.07M | 0 |
| Operating cash flow | --220.93M | -0.21%-1.91B | -496.71%-1.91B | 245.19%481.69M | 145.01%139.55M | -241.20%-310.05M | --219.58M |
| Investing cash flow | |||||||
| Net PPE purchase and sale | ---4.59B | -299.84%-1.11B | -2,363.46%-277.56M | 4.40%-11.27M | 69.16%-11.79M | -360.83%-38.21M | ---8.29M |
| Net intangibles purchase and sale | ---296.97M | -276.42%-166.92M | 31.69%-44.34M | -0.57%-64.92M | 50.13%-64.55M | 3.62%-129.43M | ---134.29M |
| Net business purchase and sale | --1.72B | 94.92%-19.36M | -37.94%-381.41M | ---276.51M | --0 | --150M | ---- |
| Net investment product transactions | ---34.51M | 88.10%-92.74M | -317.86%-779.44M | 8.19%-186.53M | -20,217.90%-203.18M | ---1M | ---- |
| Advance cash and loans provided to other parties | ---247.91M | --0 | ---- | ---- | ---- | ---- | ---- |
| Repayment of advance payments to other parties and cash income from loans | --34.47M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net changes in other investments | --20.41M | 94.20%-3.71M | -365.95%-63.94M | 9.63%-13.72M | -955.92%-15.18M | 275.99%1.77M | ---1.01M |
| Investing cash flow | ---3.4B | 9.97%-1.39B | -179.72%-1.55B | -87.63%-552.95M | -1,647.07%-294.7M | 88.25%-16.87M | ---143.59M |
| Financing cash flow | |||||||
| Net issuance payments of debt | ---2.37B | 62.38%1.53B | 359.79%944.84M | -72.96%205.49M | 53.55%759.9M | 2,476.92%494.88M | ---20.82M |
| Net common stock issuance | --6.97B | 40.77%70.42M | -98.82%50.02M | 13,520.50%4.23B | --31.05M | ---- | --39.15M |
| Increase or decrease of lease financing | --645.26M | 76,147.53%830.44M | ---1.09M | ---- | ---- | ---- | ---- |
| Net other fund-raising expenses | --45.39M | -41.78%-50.07M | 73.21%-35.32M | -126.63%-131.82M | 200.00%495M | -49,499,900.00%-495M | ---1K |
| Financing cash flow | --5.28B | 148.84%2.39B | -77.73%958.45M | 234.61%4.3B | 1,028,860.80%1.29B | -100.68%-125K | --18.33M |
| Net cash flow | |||||||
| Beginning cash position | --2.18B | -44.95%3.07B | 317.54%5.57B | 551.93%1.33B | -61.45%204.69M | 21.09%530.93M | --438.45M |
| Current changes in cash | --2.11B | 63.09%-922.41M | -159.06%-2.5B | 274.22%4.23B | 445.77%1.13B | -446.75%-327.04M | --94.32M |
| Effect of exchange rate changes | ---23.37M | 721.72%35.07M | -198.93%-5.64M | 645.65%5.7M | -229.98%-1.05M | 143.96%804K | ---1.83M |
| Cash adjustments other than cash changes | ---- | 0.00%-1K | -150.00%-1K | 100.00%2K | 200.00%1K | 50.00%-1K | ---2K |
| End cash Position | --4.26B | -28.93%2.18B | -44.95%3.07B | 317.54%5.57B | 551.93%1.33B | -61.45%204.69M | --530.93M |
| Free cash flow | ---4.66B | -42.94%-3.19B | -650.63%-2.23B | 541.50%405.51M | 113.23%63.21M | -720.42%-477.69M | --77M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |